Other
Professor Klaus Bønnelykke
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
3 recruiting
Enrollment Performance
Analytics
Phase 3
2(66.7%)
Phase 1
1(33.3%)
3Total
Phase 3(2)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06570889Phase 3Recruiting
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Role: lead
NCT06560255Phase 3Recruiting
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Role: lead
NCT06264219Phase 1Recruiting
Restoration of the Gut Microbiome After Cesarean Section
Role: lead
All 3 trials loaded